Blue Trust’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-249
Closed -$7.46K – 2651
2026
Q2
$7.46K Buy
+249
New +$7.07K ﹤0.01% 1936
2025
Q4
– Sell
-10
Closed -$346 – 2615
2025
Q3
$346 Hold
10
– – ﹤0.01% 2467
2025
Q2
$280 Hold
10
– – ﹤0.01% 2363
2025
Q1
$251 Hold
10
– – ﹤0.01% 2409
2024
Q4
$275 Sell
10
-508
-98% -$14.2K ﹤0.01% 2367
2024
Q3
$12.8K Buy
518
+247
+91% +$6.73K ﹤0.01% 2105
2024
Q2
$8.73K Buy
+271
New +$7.69K ﹤0.01% 1976
2024
Q1
– Sell
-106
Closed -$4K – 2405
2023
Q4
$4K Buy
+106
New +$3.9K ﹤0.01% 1914
2023
Q3
– Sell
-4
Closed – – 2132
2023
Q2
$0 Sell
4
-7
-64% -$286 ﹤0.01% 2222
2023
Q1
$0 Sell
11
-38
-78% -$1.56K ﹤0.01% 2435
2022
Q4
$2K Buy
49
+26
+113% +$1.09K ﹤0.01% 1922
2022
Q3
$1K Buy
+23
New +$1.18K ﹤0.01% 1926

Other funds holding LKFT

Blue Trust's LKFT Position: Q3 2026 in Review

Blue Trust sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026, closing a stake of 249 shares — an estimated $7.46K sold.

Blue Trust first reported a position in LKFT in Q3 2022 and held it in 12 quarters. The position peaked at $12.8K in Q3 2024. 67 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Blue Trust reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2026 after selling out during the quarter.
  • Blue Trust sold 249 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $7.46K.
  • Blue Trust first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2022 and held it in 12 quarters.
  • Blue Trust's Lakefront Biotherapeutics American Depositary Shares position peaked at $12.8K in Q3 2024.
  • 67 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.